Epigenetics and Inflammation in Diabetic Nephropathy

被引：33
|
作者：
Shao, Bao-Yi [1 ]
Zhang, Shao-Fei [2 ]
Li, Hai-Di [2 ]
Meng, Xiao-Ming [2 ]
Chen, Hai-Yong [3 ,4 ]
机构：
[1] Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Peoples R China
[2] Anhui Med Univ, Sch Pharm, Anhui Inst Innovat Drugs, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei, Peoples R China
[3] Univ Hong Kong, Sch Chinese Med, Hong Kong, Peoples R China
[4] Univ Hong Kong, Dept Chinese Med, Shenzhen Hosp, Shenzhen, Peoples R China
来源：
FRONTIERS IN PHYSIOLOGY | 2021年 / 12卷
关键词：
diabetic nephropathy; epigenetics; DNA methylation; histone modifications; non-coding RNAs; inflammation; THIOREDOXIN-INTERACTING PROTEIN; GLUCOSE-INDUCED INFLAMMATION; URINARY ALBUMIN EXCRETION; RENAL FIBROSIS; GENE-EXPRESSION; KIDNEY-DISEASE; DB/DB MICE; MESENCHYMAL TRANSITION; HISTONE METHYLATION; OXIDATIVE STRESS;
D O I：
10.3389/fphys.2021.649587
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
Diabetic nephropathy (DN) leads to high morbidity and disability. Inflammation plays a critical role in the pathogenesis of DN, which involves renal cells and immune cells, the microenvironment, as well as extrinsic factors, such as hyperglycemia, chemokines, cytokines, and growth factors. Epigenetic modifications usually regulate gene expression via DNA methylation, histone modification, and non-coding RNAs without altering the DNA sequence. During the past years, numerous studies have been published to reveal the mechanisms of epigenetic modifications that regulate inflammation in DN. This review aimed to summarize the latest evidence on the interplay of epigenetics and inflammation in DN, and highlight the potential targets for treatment and diagnosis of DN.
引用
收藏
页数：14
相关论文
共 50 条
  • [1] Epigenetics in the pathogenesis of diabetic nephropathy
    Li, Xue
    Lu, Lihong
    Hou, Wenting
    Huang, Ting
    Chen, Xiangyuan
    Qi, Jie
    Zhao, Yanjun
    Zhu, Minmin
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2022, 54 (02) : 163 - 172
  • [2] Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs
    Sankrityayan, Himanshu
    Kulkarni, Yogesh A.
    Gaikwad, Anil Bhanudas
    PHARMACOLOGICAL RESEARCH, 2019, 141 : 574 - 585
  • [3] Genetics and Epigenetics of Diabetic Nephropathy
    Liu, Ruijie
    Lee, Kyung
    He, John Cijiang
    KIDNEY DISEASES, 2015, 1 (01) : 42 - 51
  • [4] Epigenetics in diabetic nephropathy, immunity and metabolism
    Keating, Samuel T.
    van Diepen, Janna A.
    Riksen, Niels P.
    El-Osta, Assam
    DIABETOLOGIA, 2018, 61 (01) : 6 - 20
  • [5] Epigenetics and endoplasmic reticulum in podocytopathy during diabetic nephropathy progression
    Wang, Xiaokang
    Zhao, Jingqian
    Li, Yuanqing
    Rao, Jiaoyu
    Xu, Gengrui
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Targeting inflammation in diabetic nephropathy: a tale of hope
    Antonio Moreno, Juan
    Gomez-Guerrero, Carmen
    Mas, Sebastian
    Belen Sanz, Ana
    Lorenzo, Oscar
    Ruiz-Ortega, Marta
    Opazo, Lucas
    Mezzano, Sergio
    Egido, Jesus
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (11) : 917 - 930
  • [7] Epigenetics in diabetic nephropathy, immunity and metabolism
    Samuel T. Keating
    Janna A. van Diepen
    Niels P. Riksen
    Assam El-Osta
    Diabetologia, 2018, 61 : 6 - 20
  • [8] Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols
    Jin, Qi
    Liu, Tongtong
    Qiao, Yuan
    Liu, Donghai
    Yang, Liping
    Mao, Huimin
    Ma, Fang
    Wang, Yuyang
    Peng, Liang
    Zhan, Yongli
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [9] Regulation of Chinese Herbal Medicines in Inflammation of Diabetic Nephropathy
    Zhou Jing-Xin
    Liu Tong-Hua
    Wu Li-Li
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2020, 47 (08) : 818 - 834
  • [10] Cross Talks between Oxidative Stress, Inflammation and Epigenetics in Diabetic Retinopathy
    Kowluru, Renu. A. A.
    CELLS, 2023, 12 (02)
12345